AI assistant
Sending…
OptimizeRx Corp — Director's Dealing 2019
May 13, 2019
33090_dirs_2019-05-13_4c7b6d5d-e567-467e-a6c6-c3e1da427767.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2019-05-10
Reporting Person: BAKER DOUGLAS P (CHIEF FINANCIAL OFFICER)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-05-10 | Common Stock | M | 8334 | $3.15 | Acquired | 61885 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-05-10 | Stock Option | $3.15 | M | 8334 | Disposed | 2019-05-19 | Common Stock (8334) | Direct |
More from OptimizeRx Corp
Board/Management Information
2026
Jun 5
Proxy Solicitation & Information Statement
2026
Jun 1
Regulatory Filings
2026
May 12
Annual Report
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 30
Director's Dealing
2026
Feb 13
Director's Dealing
2025
Dec 23
Director's Dealing
2025
Dec 23
Director's Dealing
2025
Dec 23
Director's Dealing
2025
Dec 23